Discover
DMRA
Damora Therapeutics, Inc.
21.08
2 x 15.17
2 x 26.75
bid
ask
+
0.52
2.53%
2 @ 04:01 PM
21.08 +0.00 (0.00%)
| Ytd | -8.39% | |
| 1y | 42.92% |
20.43
day range
21.86
4.95
52 week range
34.14
| Open | 20.53 | Prev Close | 20.56 | Low | 20.43 | High | 21.86 | Mkt Cap | 1.30B |
| Vol | 368.73K | Avg Vol | 531.94K | EPS | -0.26 | P/E | N/A | Forward P/E | -9.70 |
| Beta | 1.44 | Short Ratio | 10.91 | Inst. Own | 105.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 26.68 | 200-d Avg | 25.98 | 1yr Est | 46.89 |
| Income Statement | |||
| Operating Expenses | 34.99M | ||
| Research and Development Expense | 25.54M | ||
| Selling, General and Administrative Expense | 9.45M | ||
| Operating Income | -34.99M | ||
| Income Tax Expense | 255.00K | ||
| Net Income | -31.17M | ||
| Net Income Common Stock | -31.17M | ||
| Net Income Common Stock (USD) | -31.17M | ||
| Consolidated Income | -31.17M | ||
| Earnings per Basic Share | -0.39 | ||
| Earnings per Basic Share (USD) | -0.39 | ||
| Earnings per Diluted Share | -0.39 | ||
| Earning Before Interest & Taxes (EBIT) | -30.92M | ||
| Earning Before Interest & Taxes (USD) | -30.92M | ||
| Weighted Average Shares | 61.12M | ||
| Weighted Average Shares Diluted | 61.12M | ||
| Balance Sheet | |||
| Cash and Equivalents | 540.52M | ||
| Cash and Equivalents (USD) | 540.52M | ||
| Current Assets | 543.59M | ||
| Total Assets | 543.64M | ||
| Current Liabilities | 27.55M | ||
| Total Liabilities | 27.58M | ||
| Accumulated Retained Earnings (Deficit) | -546.32M | ||
| Accumulated Other Comprehensive Income | 732.00K | ||
| Shareholders Equity | 516.06M | ||
| Shareholders Equity (USD) | 516.06M | ||
| Assets Non-Current | 48.00K | ||
| Liabilities Non-Current | 27.00K | ||
| Trade and Non-Trade Payables | 3.48M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.00K | ||
| Net Cash Flow from Financing | 29.51M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.64M | ||
| Issuance (Purchase) of Equity Shares | 50.95M | ||
| Net Cash Flow from Operations | -21.87M | ||
| Effect of Exchange Rate Changes on Cash | -22.00K | ||
| Share Based Compensation | 6.14M | ||